THE NATIONAL ORGANIZATION for 
              Rare Disorders (NORD)'s website <www.rarediseases.org> includes 
              information about AIDS and describes the official definition of 
              a rare disease as any that currently affects fewer than 200,000 
              Americans. 
            
              According to the CDC's latest available AIDS data, the HIV/AIDS 
              Surveillance 1998 Year-end Report (10:2, available at www.cdc.gov 
              or 800-458-5231), the number of "persons living with AIDS" 
              -- what it also calls "AIDS prevalence" (page 25) -- was 
              270,841 in 1997, the latest year for which it offers statistics.
            
              Although that figure barely lies above 200,000, it includes the 
              many AIDS cases (including a majority of initial diagnoses) that 
              involve symptom-free HIV-positive people who simply have low CD4 
              immune cell counts. And each year through 1994 -- after ten years 
              of loud official hysteria about a raging epidemic -- AIDS prevalence 
              fell bellow 200,000. It didn't even exceed 100,000 until 1991 (1997 
              Mid-year Report ). Only the 1993 AIDS redefinition, expanded 
              to include illness-free people with low CD4 counts, nudged AIDS 
              prevalence over the 200,000 mark. I couldn't find any data that 
              estimated the fraction of current AIDS patients who lack any clinical 
              illness.
            
              NORD vice-president, Maria Harden (203-746-6518 <orphan @rarediseases.org>) 
              said NORD doesn't keep a list of which diseases qualify as rare 
              because the list changes so often. 
            
              Some rare diseases eventually break the 200,000 threshold, she said, 
              and some non-rare diseases may get divided into sub-categories that 
              qualify as rare in order to qualify for the Orphan Drug Act. That 
              law gives drug companies 50 cents for every dollar they spend developing 
              drug treatments for rare diseases.
            
              So who keeps the list of diseases regarded as rare? The National 
              Institutes of Health's Office of Rare Diseases, she said. Its director, 
              Steve Groft (301-402-4336, <sg18b@nih.gov>, www.rarediseases.info.nih. 
              gov), confirmed NORD's definition of a rare disease. "It [AIDS] 
              did at one time qualify," he said. "However, once the 
              [low] T-cell count [was introduced as an AIDS condition] the number 
              of AIDS cases went over the 200,000 threshold figure. Each individual 
              opportunistic infection associated with HIV/AIDS, though, still 
              qualifies."
            
              But what about the 270,084 figure minus anybody who merely has a 
              low CD4 count but no clinical illness? Would symptomatic AIDS today 
              qualify as rare? Neither he nor anybody to whom he referred me knew 
              how many of the 270,084 living American AIDS patients had low CD4 
              counts as their only AIDS condition. As far as I can tell, nobody 
              has compiled that statistic. All we know is that according to the 
              CDC HIV/AIDS Surveillance Reports , each year since 
              1993 most new diagnoses involved people with low CD4 counts as their 
              only AIDS condition. Groft agreed that if only symptomatic patients 
              were considered, AIDS might still qualify as a rare disease, and 
              that in any case, the 270,084 figure is pretty close to rare anyway.
            
              I asked if he thought this contradicts the official message so successfully 
              received by Americans that "everyone is at risk" and that 
              AIDS is a major health threat. All he would say is that, "I 
              don't think we can be cautious enough over one source of HIV, that 
              being contaminated blood."
              -- Paul Philpott